Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$26.12 - $34.07 $12,015 - $15,672
460 Added 0.14%
339,770 $11.6 Million
Q1 2024

May 14, 2024

SELL
$26.64 - $40.31 $122,890 - $185,950
-4,613 Reduced 1.34%
339,310 $11.9 Million
Q4 2023

Feb 13, 2024

BUY
$19.95 - $31.0 $448,416 - $696,787
22,477 Added 6.99%
343,923 $9.93 Million
Q3 2023

Nov 13, 2023

BUY
$21.33 - $59.42 $700,413 - $1.95 Million
32,837 Added 11.38%
321,446 $7.36 Million
Q2 2023

Aug 11, 2023

BUY
$34.33 - $62.11 $1.77 Million - $3.2 Million
51,469 Added 21.7%
288,609 $16.5 Million
Q1 2023

May 15, 2023

BUY
$26.01 - $48.69 $7,204 - $13,487
277 Added 0.12%
237,140 $8.93 Million
Q4 2022

Feb 13, 2023

BUY
$24.14 - $30.37 $85,334 - $107,357
3,535 Added 1.52%
236,863 $6.34 Million
Q3 2022

Nov 14, 2022

BUY
$22.23 - $33.37 $5,824 - $8,742
262 Added 0.11%
233,328 $6.6 Million
Q2 2022

Aug 12, 2022

BUY
$19.74 - $43.01 $403,130 - $878,350
20,422 Added 9.6%
233,066 $5.06 Million
Q1 2022

May 13, 2022

SELL
$36.25 - $52.02 $618,787 - $887,981
-17,070 Reduced 7.43%
212,644 $8.54 Million
Q4 2021

Feb 08, 2022

BUY
$43.27 - $65.72 $121,242 - $184,147
2,802 Added 1.23%
229,714 $10.9 Million
Q3 2021

Nov 15, 2021

BUY
$53.61 - $67.5 $446,249 - $561,870
8,324 Added 3.81%
226,912 $12.9 Million
Q2 2021

Aug 13, 2021

BUY
$45.13 - $64.99 $1.84 Million - $2.65 Million
40,717 Added 22.89%
218,588 $12.5 Million
Q1 2021

May 12, 2021

SELL
$29.77 - $84.85 $80,795 - $230,282
-2,714 Reduced 1.5%
177,871 $11.3 Million
Q4 2020

Feb 11, 2021

SELL
$25.66 - $34.55 $16,602 - $22,353
-647 Reduced 0.36%
180,585 $6.06 Million
Q3 2020

Nov 16, 2020

SELL
$22.51 - $30.11 $25,053 - $33,512
-1,113 Reduced 0.61%
181,232 $4.95 Million
Q2 2020

Aug 14, 2020

BUY
$12.65 - $29.57 $1.34 Million - $3.14 Million
106,065 Added 139.05%
182,345 $4.93 Million
Q1 2020

May 14, 2020

BUY
$10.84 - $20.85 $180,323 - $346,839
16,635 Added 27.89%
76,280 $1.12 Million
Q4 2019

Feb 14, 2020

SELL
$13.02 - $19.5 $5,728 - $8,580
-440 Reduced 0.73%
59,645 $1.02 Million
Q3 2019

Nov 13, 2019

BUY
$17.46 - $29.05 $1.05 Million - $1.75 Million
60,085 New
60,085 $1.09 Million

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.